IDEX Biometrics ASA
IDXAD
$0.20
$0.10100.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 571.00K | 839.00K | 1.30M | 2.19M | 3.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 571.00K | 839.00K | 1.30M | 2.19M | 3.27M |
| Cost of Revenue | 1.53M | 1.68M | 1.61M | 2.32M | 3.23M |
| Gross Profit | -962.00K | -845.00K | -314.00K | -127.00K | 39.00K |
| SG&A Expenses | 6.54M | 8.80M | 9.88M | 11.61M | 13.05M |
| Depreciation & Amortization | 2.27M | 2.52M | 1.61M | 2.37M | 1.68M |
| Other Operating Expenses | 6.88M | 7.29M | 7.09M | 8.06M | 8.66M |
| Total Operating Expenses | 19.63M | 22.74M | 22.59M | 26.20M | 28.67M |
| Operating Income | -19.06M | -21.91M | -21.29M | -24.01M | -25.40M |
| Income Before Tax | -13.29M | -14.57M | -15.63M | -24.03M | -24.83M |
| Income Tax Expenses | -118.00K | -120.00K | 17.00K | 12.00K | -20.00K |
| Earnings from Continuing Operations | -13.17 | -14.45 | -15.65 | -24.04 | -24.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.17M | -14.45M | -15.65M | -24.04M | -24.81M |
| EBIT | -19.06M | -21.91M | -21.29M | -24.01M | -25.40M |
| EBITDA | -17.34M | -20.01M | -19.38M | -21.94M | -24.03M |
| EPS Basic | -3.06 | -4.50 | -5.55 | -8.63 | -9.22 |
| Normalized Basic EPS | -1.99 | -3.19 | -3.83 | -5.39 | -5.77 |
| EPS Diluted | -3.06 | -4.56 | -5.62 | -9.05 | -9.76 |
| Normalized Diluted EPS | -1.99 | -3.19 | -3.83 | -5.37 | -5.75 |
| Average Basic Shares Outstanding | 19.64M | 14.12M | 11.63M | 11.17M | 10.84M |
| Average Diluted Shares Outstanding | 19.66M | 14.14M | 11.67M | 11.21M | 10.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |